Figure 2
From: Serum anti-AP3D1 antibodies are risk factors for acute ischemic stroke related with atherosclerosis
Comparing the levels of serum antibodies against AP3D1 between HDs and patients with DM. The s-AP3D1-Abs levels in HDs and patients with diabetes mellitus (DM) examined using AlphaLISA are shown (a). The bars represent the average and average ± SD. P-values were calculated using the Mann–Whitney U test. ***P < 0.001. The data are summarized in Table 2. ROC curves to assess the ability of s-AP3D1-Abs to predict DM are shown (b). The numbers in the figures are the same as those shown in Fig. 1. The results of the power calculation were shown in Supplementary Table S3.
